Buchmann A - Search Results

1

Role of connexin32 and beta-catenin in tumor promotion in mouse liver.

Schwarz M, Wanke I, Wulbrand U, Moennikes O, Buchmann A. Schwarz M, et al. Among authors: buchmann a. Toxicol Pathol. 2003 Jan-Feb;31(1):99-102. doi: 10.1080/01926230390173932. Toxicol Pathol. 2003. PMID: 12597453 Review.

2

Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.

Loeppen S, Schneider D, Gaunitz F, Gebhardt R, Kurek R, Buchmann A, Schwarz M. Loeppen S, et al. Among authors: buchmann a. Cancer Res. 2002 Oct 15;62(20):5685-8. Cancer Res. 2002. PMID: 12384525

3

WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.

Moennikes O, Stahl S, Bannasch P, Buchmann A, Schwarz M. Moennikes O, et al. Among authors: buchmann a. Carcinogenesis. 2003 Sep;24(9):1561-5. doi: 10.1093/carcin/bgg099. Epub 2003 Jun 19. Carcinogenesis. 2003. PMID: 12819187

4

A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.

Loeppen S, Koehle C, Buchmann A, Schwarz M. Loeppen S, et al. Among authors: buchmann a. Carcinogenesis. 2005 Jan;26(1):239-48. doi: 10.1093/carcin/bgh298. Epub 2004 Oct 7. Carcinogenesis. 2005. PMID: 15471898

5

Effect of the tumor promoter phenobarbital on the pattern of global gene expression in liver of connexin32-wild-type and connexin32-deficient mice.

Stahl S, Ittrich C, Marx-Stoelting P, Köhle C, Ott T, Buchmann A, Schwarz M. Stahl S, et al. Among authors: buchmann a. Int J Cancer. 2005 Jul 20;115(6):861-9. doi: 10.1002/ijc.20815. Int J Cancer. 2005. PMID: 15751032

6

Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.

Rignall B, Braeuning A, Buchmann A, Schwarz M. Rignall B, et al. Among authors: buchmann a. Carcinogenesis. 2011 Jan;32(1):52-7. doi: 10.1093/carcin/bgq226. Epub 2010 Nov 3. Carcinogenesis. 2011. PMID: 21047994

7

The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains.

Moennikes O, Buchmann A, Ott T, Willecke1 K, Schwarz M. Moennikes O, et al. Among authors: buchmann a. Carcinogenesis. 1999 Jul;20(7):1379-82. doi: 10.1093/carcin/20.7.1379. Carcinogenesis. 1999. PMID: 10383916

8

Hepatocarcinogenesis in female mice with mosaic expression of connexin32.

Moennikes O, Buchmann A, Willecke K, Traub O, Schwarz M. Moennikes O, et al. Among authors: buchmann a. Hepatology. 2000 Sep;32(3):501-6. doi: 10.1053/jhep.2000.16598. Hepatology. 2000. PMID: 10960441

9

Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.

Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J, Willecke K, Schwarz M. Moennikes O, et al. Among authors: buchmann a. Cancer Res. 2000 Sep 15;60(18):5087-91. Cancer Res. 2000. PMID: 11016633

10

Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.

Aydinlik H, Nguyen TD, Moennikes O, Buchmann A, Schwarz M. Aydinlik H, et al. Among authors: buchmann a. Oncogene. 2001 Nov 22;20(53):7812-6. doi: 10.1038/sj.onc.1204982. Oncogene. 2001. PMID: 11753661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters